We identified PHLDA3 as a p53 target gene and found that its protein product is a suppressor of pancreatic neuroendocrine tumors (PanNETs) and a repressor of Akt function. This evidence concerns the gene PHLDA3 and pancreatic neuroendocrine tumor.